Active immunoprophylaxis in burns with a new multivalent vaccine.
D000293:Adolescent; D000368:Aged; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000008:administration & dosage; D002056:Burns / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000401:mortality / Q000628:therapy*; D002648:Child; D006801:Humans; D007111:Immunity, Cellular; D017053:Infection Control; D007239:Infections / Q000401:mortality; D008297:Male; D008712:Methicillin / Q000494:pharmacology; D010403:Penicillin Resistance; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D013208:Staphylococcal Toxoid; D013209:Staphylococcal Vaccines; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D014611:Vaccination
D000906:Antibodies; D001428:Bacterial Vaccines; D013208:Staphylococcal Toxoid; D013209:Staphylococcal Vaccines; D008712:Methicillin